853 related articles for article (PubMed ID: 24120997)
1. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
Esteves AR; Gozes I; Cardoso SM
Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
[TBL] [Abstract][Full Text] [Related]
2. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic.
Arduíno DM; Esteves AR; Cortes L; Silva DF; Patel B; Grazina M; Swerdlow RH; Oliveira CR; Cardoso SM
Hum Mol Genet; 2012 Nov; 21(21):4680-702. PubMed ID: 22843496
[TBL] [Abstract][Full Text] [Related]
4. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.
Bir A; Sen O; Anand S; Khemka VK; Banerjee P; Cappai R; Sahoo A; Chakrabarti S
J Neurochem; 2014 Dec; 131(6):868-77. PubMed ID: 25319443
[TBL] [Abstract][Full Text] [Related]
6. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
[TBL] [Abstract][Full Text] [Related]
7. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
[TBL] [Abstract][Full Text] [Related]
8. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model.
Park HJ; Shin JY; Kim HN; Oh SH; Lee PH
Neurobiol Aging; 2014 Aug; 35(8):1920-8. PubMed ID: 24629674
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease.
Cardoso SM; Esteves AR; Arduíno DM
Neurodegener Dis; 2012; 10(1-4):38-40. PubMed ID: 22156537
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Pozo Devoto VM; Falzone TL
Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models.
Oh SH; Lee SC; Kim DY; Kim HN; Shin JY; Ye BS; Lee PH
Stem Cells; 2017 Aug; 35(8):1934-1947. PubMed ID: 28580639
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
Chen J; Ren Y; Gui C; Zhao M; Wu X; Mao K; Li W; Zou F
Cell Death Dis; 2018 Jun; 9(6):700. PubMed ID: 29899409
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Rocha EM; De Miranda B; Sanders LH
Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
[TBL] [Abstract][Full Text] [Related]
15. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.
Jinn S; Drolet RE; Cramer PE; Wong AH; Toolan DM; Gretzula CA; Voleti B; Vassileva G; Disa J; Tadin-Strapps M; Stone DJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2389-2394. PubMed ID: 28193887
[TBL] [Abstract][Full Text] [Related]
16. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
[TBL] [Abstract][Full Text] [Related]
17. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
18. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
[TBL] [Abstract][Full Text] [Related]
19. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM
Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383
[TBL] [Abstract][Full Text] [Related]
20. Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study.
Aimaiti M; Wumaier A; Aisa Y; Zhang Y; Xirepu X; Aibaidula Y; Lei X; Chen Q; Feng X; Mi N
Eur J Pharmacol; 2021 Jul; 903():174136. PubMed ID: 33940032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
